Inventor
Symon GATHIAKA
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes19%
C07BGeneral methods of organic chemistry14%
C07DHeterocyclic compounds14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
C07KPeptides10%
PatentTitleYear
12,297,208Small molecule inhibitors of KRAS G12C mutant202512,291,538Small molecule inhibitors of KRAS G12C mutant202512,240,867Arginase inhibitors and methods of use202512,215,116Arginase inhibitors and methods of use202511,697,657Small molecule inhibitors of KRAS G12C mutant202311,274,111Arginase inhibitors and methods of use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to MERCK SHARP & DOHME (1)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to MERCK SHARP & DOHME LLC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 5 | 2023–2025 |
| MERCK SHARP & DOHME | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |